Why These Stocks Are Trading Up Premarket

Featured

ServiceSource (SREV) reported Q4 EPS of $0.01, may not compare to the analyst estimate of ($0.07). Revenue for the quarter came in at $74.7 million versus the consensus estimate of $67.55 million.

Xinyuan Real Estate (XIN) reported Q4 EPS of $0.34, versus $0.10 reported last year. Revenue for the quarter came in at $362.9 million, versus $163.6 million reported last year.

Infoblox (BLOX) reported Q2 EPS of $0.09, $0.04 better than the analyst estimate of $0.05. Revenue for the quarter came in at $74.3 million versus the consensus estimate of $68.2 million.

Clean Energy Fuels (CLNE) reported Q4 EPS of $0.11, $0.28 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $132.1 million versus the consensus estimate of $111.2 million.

Monster Beverage (MNST) reported Q4 EPS of $0.72, $0.13 better than the analyst estimate of $0.59. Revenue for the quarter came in at $696.3 million versus the consensus estimate of $584.56 million.

Sandridge Energy (SD) reported Q4 EPS of $0.08, $0.08 better than the analyst estimate of $0.00. Revenue for the quarter came in at $346.88 million versus the consensus estimate of $397.46 million.

Splunk (SPLK) reported Q4 EPS of $0.09, $0.05 better than the analyst estimate of $0.04. Revenue for the quarter came in at $147.4 million versus the consensus estimate of $137.05 million.

Atossa Genetics (ATOS) Announces CAP Accreditation for NRLBH

Horizon Pharma (HZNP) reported Q4 EPS of $0.27, $0.05 better than the analyst estimate of $0.22. Revenue for the quarter came in at $103.8 million versus the consensus estimate of $95.5 million.

Aruba Networks (ARUN) reported Q2 EPS of $0.30, $0.03 better than the analyst estimate of $0.27. The company posted revs of $212.9 million, versus the consensus of $210.2 million. Sees Q3 EPS of $0.26 – $0.30, with the consensus at $0.27.

Taser (TASR) Yesterday’s post-earnings pullback of Taser was a “massive overreaction,” say Craig-Hallum analysts Steven Dyer and Greg Palm, pointing to the company’s video bookings which grew 60% sequentially during the quarter and average revenue per unit which was up over 20%.

Digitalglobe, Inc. (DGI) reported Q4 EPS of $0.14, may not compare the analyst estimate of $0.06. Revenue for the quarter came in at $185.7 million versus the consensus estimate of $180.2 million.

Mobileye N.V (MBLY) Raymond James upgraded Mobileye N.V from Market Perform to Outperform with a price target of $49.00.

Why These Stocks Are Trading Down Premarket

Featured

Potbelly Corp (PBPB) Piper Jaffray downgraded Potbelly Corp from Overweight to Underweight with a price target of $12.00 (from $16.00) following CFO departure.

CVSL (CVSL) Prices 6.7M Common, Warrants Offering at $3/Unit

Resonant (RESN) reported Q4 EPS of ($0.31), versus ($6.13) reported last year. Revenue for the quarter came in at $921.1 million, versus $437 million reported last year.

TubeMogul (TUBE) reported Q4 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $36.1 million versus the consensus estimate of $32.2 million. TubeMogul sees Q1 2015 revenue of $28-30 million, versus the consensus of $31.6 million.

Weight Watchers International (WTW) reported Q4 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $327.8 million versus the consensus estimate of $332.7 million. Weight Watchers International sees FY2015 EPS of $0.40-$0.70, versus the consensus of $1.43.

Raptor Pharma (RPTP) reported Q4 EPS of ($0.29), $0.15 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $17.3 million versus the consensus estimate of $20.12 million.

JCPenney (JCP) reported Q4 EPS of $0.00, $0.74 worse than the analyst estimate of $0.74. Revenue for the quarter came in at $3.89 billion versus the consensus estimate of $4.71 billion. Operating income for the quarter was $63 million, which represents a $201 million increase over last year.

Novavax (NVAX) reported Q4 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08).

Ocwen Financial Corp (OCN) Compass Point downgraded Ocwen Financial Corp from Neutral to Sell with a price target of $7.00 (from $7.50). Analyst Kevin Barker thinks litigation and operation risks are high.

Frontline (FRO) Record Levels Of Oil In Storage Foreshadowing Opportunity In Tankers

Ziopharm Oncology (ZIOP) reported Q4 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14).

CyberArk Software (CYBR) files to offer $200 million in ordinary shares.

Concho Resources (CXO) Prices Larger 6M Common Offering for Proceeds of $650M

GREK Germany approves Greek bailout extension

Herbalife (HLF) investors were treated to more nonsense Thursday evening when the company released its 10K.